| Literature DB >> 34776563 |
Bogusław Buszewski1,2, Ewelina Maślak1,2, Michał Złoch1, Viorica Railean-Plugaru1, Ewa Kłodzińska3, Paweł Pomastowski1.
Abstract
Fast determination, identification and characterization of pathogens is a significant challenge in many fields, from industry to medicine. Standard approaches (e.g., culture media and biochemical tests) are known to be very time-consuming and labor-intensive. Conversely, screening techniques demand a quick and low-cost grouping of microbial isolates, and current analysis call for broad reports of pathogens, involving the application of molecular, microscopy, and electromigration techniques, DNA fingerprinting and also MALDI-TOF methods. The present COVID-19 pandemic is a crisis that affects rich and poor countries alike. Detection of SARS-CoV-2 in patient samples is a critical tool for monitoring disease spread, guiding therapeutic decisions and devising social distancing protocols. The goal of this review is to present an innovative methodology based on preparative separation of pathogens by electromigration techniques in combination with simultaneous analysis of the proteome, lipidome, and genome using laser desorption/ionization analysis.Entities:
Keywords: Capillary electrophoresis; Identification; Laser desorption/ionization; Pre-concentration; Virus
Year: 2021 PMID: 34776563 PMCID: PMC8573725 DOI: 10.1016/j.trac.2021.116250
Source DB: PubMed Journal: Trends Analyt Chem ISSN: 0165-9936 Impact factor: 14.908
Fig. 1Pathogen identification approaches with particular regard to viruses.
Fig. 2Coupling electromigration techniques with laser desorption/ionization approach in virus analysis.
Fig. 3Laser desorption/ionization analysis of virus molecular compounds.
Summary of virus analyses by approach to pathogen identification (n/a - not available).
| Virus | Sample source | Analytical Method | No. of samples | Reference |
|---|---|---|---|---|
| HBV, HCV | serum | PCR | 730 | [ |
| Enteric viruses | stool samples | monoplex or multiplex RT-PCR | 227 | [ |
| HRSV | nasopharyngeal and oropharyngeal swab | real-time RT-PCR | 334 | [ |
| DENV, ZIKV | serum | RT-qPCR | 46 | [ |
| Respiratory viruses | throat swabs and sputum samples | RT-qPCR | 408 | [ |
| Respiratory viruses | nasopharyngeal aspirates, nasopharyngeal and oral pharyngeal swab | rRT-PCR | 8173 | [ |
| SARS-CoV-2 | sputum, nose and throat swabs | real-time RT-PCR | 297 | [ |
| LASV | serum, lung and spleen tissue, blood | RT-qPCR | 82 | [ |
| Respiratory viruses | respiratory tract swabs and aspirates | MALDI-TOF MS | 58 | [ |
| HR HPV | uterine cervix cytology | MALDI-TOF MS | 356 | [ |
| Poliovirus | cerebrospinal fluid, throat swab, stool samples | MALDI-TOF MS | 5 | [ |
| SARS-CoV-2 | nasal swab | MALDI-MS + machine learning analysis | 362 | [ |
| Enterovirus EV71 | serum | LDI-MS with cellulose acetate membranę and Ag or Au NPs | n/a | [ |
| HIV, HCV | serum | SELDI MS | 151 | [ |
| Bacteriophages | ||||
| Triaviruses, Phietaviruses, Biseptimaviruses, Kayviruses, Twortvirus, P68virus | reference and isolates | MALDI-TOF MS | n/a | [ |
| vB-SdyS-ISF003 | wastewater and sewage | PCR and sequencing DNA | n/a | [ |
| medicamente isolate | CZE, MALDI-TOF MS | n/a | [ | |
| Staphylococcal phages (K1/420, 11, P68) | physiological saline solution, human serum | MALDI-TOF MS | n/a | [ |
| Staphylococcal phages (K1/420, 11, P68, 3A, 77) | blood, serum | MALDI-TOF MS | n/a | [ |
Fig. 4Future perspectives of lab-on-a-chip.